{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:30:40Z","timestamp":1773729040598,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1124\/dmd.117.077669","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:30:24Z","timestamp":1503621024000},"page":"1149-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms"],"prefix":"10.1016","volume":"45","author":[{"given":"Xinwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Rida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry E.","family":"Bleske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.077669_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/dmd.116.074732","article-title":"Global proteomic analysis of human liver microsomes: rapid characterization and quantification of hepatic drug-metabolizing enzymes","volume":"45","author":"Achour","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1291\/hypres.28.719","article-title":"A single nucleotide polymorphism in the carboxylesterase gene is associated with the responsiveness to imidapril medication and the promoter activity","volume":"28","author":"Geshi","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1124\/dmd.117.077669_bib3","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1124\/dmd.109.028498","article-title":"A possible mechanism for the differences in efficiency and variability of active metabolite formation from thienopyridine antiplatelet agents, prasugrel and clopidogrel","volume":"37","author":"Hagihara","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0090-9556(25)06743-1","article-title":"Interindividual variation in carboxylesterase levels in human liver microsomes","volume":"23","author":"Hosokawa","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.117.077669_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.117.077669_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.113.054353","article-title":"Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis","volume":"42","author":"Laizure","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e32835aa8a2","article-title":"The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response","volume":"23","author":"Lewis","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.117.077669_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cts.12423","article-title":"Population pharmacokinetics of methylphenidate in healthy adults emphasizing novel and known effects of several carboxylesterase 1 (CES1) variants","volume":"9","author":"Lyauk","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.117.077669_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.neuropharm.2009.08.014","article-title":"Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD","volume":"57","author":"Nemoda","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.117.077669_bib11","doi-asserted-by":"crossref","unstructured":"Nzabonimpa GS, Rasmussen HB, Brunak S, Taboureau O, and Consortium I (2016) Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches. Drug Metab Pers Ther DOI: 10.1515\/dmpt-2015-0034 [published ahead of print].","DOI":"10.1515\/dmpt-2015-0034"},{"key":"10.1124\/dmd.117.077669_bib12","doi-asserted-by":"crossref","first-page":"e0176320","DOI":"10.1371\/journal.pone.0176320","article-title":"The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans","volume":"12","author":"Oh","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/dmd.117.077669_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/pgs.15.7","article-title":"Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics","volume":"16","author":"Rasmussen","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1124\/dmd.117.077669_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.abb.2012.04.010","article-title":"Examination of the carboxylesterase phenotype in human liver","volume":"522","author":"Ross","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.117.077669_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2125.2010.03695.x","article-title":"Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients","volume":"70","author":"Sai","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib16","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.117.077669_bib17","doi-asserted-by":"crossref","unstructured":"Shi J, Wang X, Eyler RF, Liang Y, Liu L, Mueller BA, Zhu HJ (2016a) Association of oseltamivir activation with gender and carboxylesterase 1 genetic polymorphisms. Basic Clin Pharmacol Toxicol 119:555\u2013561.","DOI":"10.1111\/bcpt.12625"},{"key":"10.1124\/dmd.117.077669_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1124\/dmd.115.068536","article-title":"Sacubitril is selectively activated by carboxylesterase 1 (CES1) in the liver and the activation is affected by CES1 genetic variation","volume":"44","author":"Shi","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bcp.2016.09.003","article-title":"Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender","volume":"119","author":"Shi","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/bcp.13237","article-title":"The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects","volume":"83","author":"Stage","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/clpt.2012.13","article-title":"Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans","volume":"92","author":"Tarkiainen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.077669_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/cpt.101","article-title":"Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans","volume":"97","author":"Tarkiainen","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.117.077669_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/bcp.12667","article-title":"Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril","volume":"80","author":"Tarkiainen","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/rcm.7482","article-title":"Targeted absolute quantitative proteomics with SILAC internal standards and unlabeled full-length protein calibrators (TAQSI)","volume":"30","author":"Wang","year":"2016","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.117.077669_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/tpj.2015.42","article-title":"CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors","volume":"16","author":"Wang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.117.077669_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bcp.2008.10.005","article-title":"Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin","volume":"77","author":"Yang","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bbrc.2008.02.120","article-title":"Functional polymorphisms in carboxylesterase1A2 (CES1A2) gene involves specific protein 1 (Sp1) binding sites","volume":"369","author":"Yoshimura","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.117.077669_bib28","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1124\/dmd.109.028209","article-title":"Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver","volume":"37","author":"Zhu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib29","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bcp.2008.12.017","article-title":"Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril","volume":"77","author":"Zhu","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.077669_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/dmd.108.024943","article-title":"Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants","volume":"37","author":"Zhu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.117.077669_bib31","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1124\/dmd.117.077669_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation","volume":"344","author":"Zhu","year":"2013","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624054448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.077669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:33:15Z","timestamp":1739903595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624054448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0090955624054448"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.077669","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comprehensive Functional Assessment of Carboxylesterase 1 Nonsynonymous Polymorphisms","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.077669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}